Search

Search Constraints

You searched for: Author/Creator Signoriello, Elisabetta

Search Results

1. Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study. (August 2019)

2. A real‐world study of alemtuzumab in a cohort of Italian patients. (5th October 2021)

3. Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study. (April 2018)

4. Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. Issue 12 (30th September 2022)

5. Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies. (November 2022)

6. Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab. Issue 3 (10th May 2022)

7. Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy. (January 2022)

8. Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience. (October 2020)

9. Cladribine vs other drugs in MS: Merging randomized trial with real-life data. Issue 6 (November 2020)

10. Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study. (28th November 2017)